Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion

Aug 20, 2024, 11:53 AM

Johnson & Johnson has announced its agreement to acquire V-Wave, a privately-held company specializing in innovative treatment options for heart failure. The acquisition involves an upfront payment of $600 million, with the total deal potentially reaching up to $1.1 billion, contingent on achieving specific milestones. Some reports suggest the deal could be worth up to $1.7 billion. This strategic move aims to enhance Johnson & Johnson's MedTech cardiovascular portfolio, particularly through V-Wave's innovative Ventura® technology.